TY - JOUR T1 - The use of inhaled corticosteroids in the wheezy under 5-year-old child JF - Archives of disease in childhood - Education & practice edition JO - Arch Dis Child Educ Pract Ed SP - 61 LP - 66 DO - 10.1136/adc.2009.171272 VL - 96 IS - 2 AU - B R Davies AU - W D Carroll Y1 - 2011/04/01 UR - http://ep.bmj.com/content/96/2/61.abstract N2 - Inhaled corticosteroids are established as the most effective long-term anti-inflammatory therapy for asthma. National and international treatment guidelines recommend the use of these agents for long-term asthma control in children. In children <5 years, there are significant difficulties in diagnosing asthma. There are multiple non-asthma causes of wheeze, and there remains a lack of consensus in the description of wheezing phenotypes in this group of children. There is also a relative paucity of data concerning the short- and long-term effectiveness and side-effects in the under-fives: treatment recommendations have drawn heavily from experience of asthma treatment in school-age children and remains controversial. This article discusses the important recent advances in the evidence-base and current expert opinions which are helping to delineate improved outcomes for young children with wheeze. ER -